Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-09

Clinical Trial Update: FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

View source ↗

Summary

A post-market interventional study of the Evolut PRO transcatheter aortic valve replacement system has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Aortic Valve Stenosis | Status: COMPLETED